These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2471768)

  • 21. Prothrombotic changes in children with sickle cell disease: relationships to cerebrovascular disease and transfusion.
    Liesner R; Mackie I; Cookson J; McDonald S; Chitolie A; Donohoe S; Evans J; Hann I; Machin S
    Br J Haematol; 1998 Dec; 103(4):1037-44. PubMed ID: 9886316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma heparin cofactor II, protein C and antithrombin in elective surgery.
    Andersson TR; Berner NS; Larsen ML; Odegaard OR; Abildgaard U
    Acta Chir Scand; 1987 Apr; 153(4):291-6. PubMed ID: 3630527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma heparin cofactor II and antithrombin III concentrations in adult nephrotic syndrome.
    Hannedouche T; Fischer AM; Blanche P; Tapon-Brétaudière J; Ganeval D
    Clin Nephrol; 1987 Dec; 28(6):305-6. PubMed ID: 3442960
    [No Abstract]   [Full Text] [Related]  

  • 24. Involvement of heparin cofactor II in chymotrypsin neutralization and in the pancreatic proteinase-antiproteinase interaction during acute pancreatitis in man.
    Toulon P; Chadeuf G; Bouillot JL; Amiral J; Cambillau M; Sultan Y; Aiach M
    Eur J Clin Invest; 1991 Jun; 21(3):303-9. PubMed ID: 1909634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Standardization of the laboratory method for antithrombin activity measurement].
    Okajima K
    Rinsho Byori; 2002 Mar; 50(3):283-6. PubMed ID: 11985057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation between coagulation and fibrinolysis in patient with cerebrovascular accident at acute stage].
    Takemoto Y; Fukuda A; Tanaka S; Tanabe J; Ikeda H; Fujii C; Kohama A
    No To Shinkei; 1982 Oct; 34(10):1007-10. PubMed ID: 7150448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of interference by heparin cofactor II in the DuPont aca antithrombin-III assay.
    Hortin GL; Tollefsen DM; Santoro SA
    Am J Clin Pathol; 1988 Apr; 89(4):515-7. PubMed ID: 3354504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laboratory diagnosis of antithrombin and heparin cofactor II deficiency.
    Tollefsen DM
    Semin Thromb Hemost; 1990 Apr; 16(2):162-8. PubMed ID: 2191430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Inhibition mechanism of blood coagulation--especially on the function of antithrombin III].
    Sakuragawa N
    Rinsho Byori; 1985 Sep; 33(9):974-81. PubMed ID: 3841167
    [No Abstract]   [Full Text] [Related]  

  • 30. The anticoagulant and antithrombotic mechanisms of heparin.
    Gray E; Hogwood J; Mulloy B
    Handb Exp Pharmacol; 2012; (207):43-61. PubMed ID: 22566220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin and antithrombin III levels during cardiopulmonary bypass: correlation with subclinical plasma coagulation.
    Hashimoto K; Yamagishi M; Sasaki T; Nakano M; Kurosawa H
    Ann Thorac Surg; 1994 Sep; 58(3):799-804; discussion 804-5. PubMed ID: 7944706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
    Gold HK; Torres FW; Garabedian HD; Werner W; Jang IK; Khan A; Hagstrom JN; Yasuda T; Leinbach RC; Newell JB
    J Am Coll Cardiol; 1993 Apr; 21(5):1039-47. PubMed ID: 8459055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin.
    Bray B; Lane DA; Freyssinet JM; Pejler G; Lindahl U
    Biochem J; 1989 Aug; 262(1):225-32. PubMed ID: 2818566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indices of hypercoagulation in cancer as compared with those in acute inflammation and acute infarction.
    Lindahl AK; Sandset PM; Abildgaard U
    Haemostasis; 1990; 20(5):253-62. PubMed ID: 2289706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin cofactor II deficiency in the elderly: comparison with antithrombin III.
    Kario K; Matsuo T; Kobayashi H
    Thromb Res; 1992 Jun; 66(5):489-98. PubMed ID: 1381849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin cofactor II, antithrombin and protein C in plasma from term and preterm infants.
    Andersson TR; Bangstad H; Larsen ML
    Acta Paediatr Scand; 1988 Jul; 77(4):485-8. PubMed ID: 3394503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hypercoagulation and recurrence of cerebral infarct].
    Landi GL; Anzalone N; Morabito A; D'Angelo A; Mannucci PM
    G Clin Med; 1989; 70(6-7):415-6, 418-9. PubMed ID: 2527773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma heparin cofactor II in alcoholic liver disease.
    Andersson TR; Bell H
    J Hepatol; 1988 Aug; 7(1):79-84. PubMed ID: 3183355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation.
    Despotis GJ; Levine V; Joist JH; Joiner-Maier D; Spitznagel E
    Anesth Analg; 1997 Sep; 85(3):498-506. PubMed ID: 9296400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats.
    Choi G; Hofstra JJ; Roelofs JJ; Rijneveld AW; Bresser P; van der Zee JS; Florquin S; van der Poll T; Levi M; Schultz MJ
    Crit Care Med; 2008 Jan; 36(1):204-10. PubMed ID: 18090375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.